- Home
- ESOA vs AVTX Comparison
ESOA vs AVTX Comparison
Compare ESOA & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESOA | AVTX |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.2M | 328.4M |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ESOA | AVTX |
|---|---|---|
| Price | $17.67 | $16.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $21.00 | ★ $40.57 |
| AVG Volume (30 Days) | 144.2K | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $122,465,826.00 | $27,813,137.00 |
| Revenue This Year | $9.22 | N/A |
| Revenue Next Year | $3.77 | N/A |
| P/E Ratio | $103.82 | ★ N/A |
| Revenue Growth | 2.74 | ★ 2312.27 |
| 52 Week Low | $7.84 | $3.43 |
| 52 Week High | $19.94 | $24.27 |
Technical Indicators
Market Signals| Indicator | ESOA | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.89 | 50.47 |
| Support Level | $16.62 | $13.70 |
| Resistance Level | $19.94 | $19.39 |
| Average True Range (ATR) | 1.11 | 1.96 |
| MACD | -0.11 | -0.31 |
| Stochastic Oscillator | 30.12 | 31.53 |
Price Performance
Historical ComparisonAbout ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.